Effect of liposomal celecoxib on proliferation of colon cancer cell and inhibition of DMBA-induced tumor in rat model

Celecoxib, a selective cyclooxygenase-2 inhibitor, has shown potential anticancerous activity against majority of solid tumors especially on patients with colon cancer. However, associations of serious side effects limit the usage of celecoxib in colon cancer treatment. To address this issue and pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Perumal, Venkatesan, Banerjee, Shubhadeep, Das, Shubasis, Sen, R. K., Mandal, Mahitosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2011
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451972/
https://www.ncbi.nlm.nih.gov/pubmed/26069486
http://dx.doi.org/10.1007/s12645-011-0017-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451972/
https://www.ncbi.nlm.nih.gov/pubmed/26069486
http://dx.doi.org/10.1007/s12645-011-0017-5

Ejemplares similares